A. Nogami

发表

Inhibition of the STAT5/Pim Kinase Axis Enhances Cytotoxic Effects of Proteasome Inhibitors on FLT3-ITD–Positive AML Cells by Cooperatively Inhibiting the mTORC1/4EBP1/S6K/Mcl-1 Pathway1

O. Miura, A. Nogami, Keigo Okada, 2018, Translational oncology.

Proliferation and Survival Signaling from Both Jak2-V617F and Lyn Involving GSK3 and mTOR/p70S6K/4EBP1 in PVTL-1 Cell Line Newly Established from Acute Myeloid Leukemia Transformed from Polycythemia Vera

T. Kurosu, O. Miura, S. Tohda, 2014, PloS one.

FLT3-ITD induces expression of Pim kinases through STAT5 to confer resistance to the PI3K/Akt pathway inhibitors on leukemic cells by enhancing the mTORC1/Mcl-1 pathway

O. Miura, A. Nogami, Keigo Okada, 2017, Oncotarget.

Inhibition of USP9X Downregulates JAK2-V617F and Induces Apoptosis Synergistically with BH3 Mimetics Preferentially in Ruxolitinib-Persistent JAK2-V617F-Positive Leukemic Cells

O. Miura, A. Nogami, Keigo Okada, 2020, Cancers.

Severe Motor Weakness Due to Disturbance in Peripheral Nerves Following Tisagenlecleucel Treatment

O. Miura, A. Nogami, Keigo Okada, 2021, In Vivo.

Inhibition of USP9X induces apoptosis in FLT3-ITD-positive AML cells cooperatively by inhibiting the mutant kinase through aggresomal translocation and inducing oxidative stress.

O. Miura, A. Nogami, Keigo Okada, 2019, Cancer letters.

Molecular mechanisms for enhancement of stromal cell-derived factor 1–induced chemotaxis by platelet endothelial cell adhesion molecule 1 (PECAM-1)

T. Kurosu, O. Miura, G. Oshikawa, 2017, The Journal of Biological Chemistry.

Establishment and characterization of a new activated B-cell-like DLBCL cell line, TMD12.

Kouhei Yamamoto, Kota Yoshifuji, A. Nogami, 2022, Experimental hematology.

Therapeutic Advances in Immunotherapies for Hematological Malignancies

K. Sasaki, A. Nogami, Ayako Nogami, 2022, International journal of molecular sciences.

Mechanisms for mTORC1 activation and synergistic induction of apoptosis by ruxolitinib and BH3 mimetics or autophagy inhibitors in JAK2-V617F-expressing leukemic cells including newly established PVTL-2

O. Miura, G. Oshikawa, A. Nogami, 2018, Oncotarget.

Sepsis Caused by Newly Identified Capnocytophaga canis Following Cat Bites: C. canis Is the Third Candidate along with C. canimorsus and C. cynodegmi Causing Zoonotic Infection

Takuhiro Yoshida, Y. Shimojima, K. Imaoka, 2017, Internal medicine.

Elevated serum lipoprotein (a) levels associated with ulcerative colitis in a young Japanese patient.

R. Arima, S. Tarui, M. Gomi, 1997, Internal medicine.

Sequential monitoring of serum IL-6, TNF-α, and IFN-γ levels in a CAEBV patient treated by plasma exchange and immunochemotherapy

O. Miura, M. Kurata, A. Arai, 2012, International Journal of Hematology.

Down regulation of Chk1 by p53 plays a role in synergistic induction of apoptosis by chemotherapeutics and inhibitors for Jak2 or BCR/ABL in hematopoietic cells

T. Kurosu, O. Miura, A. Nogami, 2016, Oncotarget.

FLT3-ITD Activates RSK1 to Enhance Proliferation and Survival of AML Cells by Activating mTORC1 and eIF4B Cooperatively with PIM or PI3K and by Inhibiting Bad and BIM

O. Miura, A. Nogami, Keigo Okada, 2019, Cancers.

FLT3-ITD confers resistance to the PI3K/Akt pathway inhibitors by protecting the mTOR/4EBP1/Mcl-1 pathway through STAT5 activation in acute myeloid leukemia

T. Kurosu, O. Miura, G. Oshikawa, 2015, Oncotarget.

A Novel Protease-Mediated Chimeric Antigen Receptor (CAR): "Double-Arm" CAR-T Cell System Improves Target Specificity of CAR-T Cell Therapy

N. Kawamata, O. Miura, A. Nogami, 2019, Blood.

A novel chimeric antigen receptor (CAR) system using an exogenous protease, in which activation of T cells is controlled by expression patterns of cell-surface proteins on target cells

O. Miura, Huixin Li, A. Nogami, 2022, International journal of molecular medicine.

Characterization of three strains of Capnocytophaga canis isolated from patients with sepsis

S. Morikawa, M. Mohri, Y. Shimojima, 2018, Microbiology and immunology.

A novel MYD88 mutation, L265RPP, in Waldenström macroglobulinemia activates the NF-κB pathway to upregulate Bcl-xL expression and enhances cell survival

T. Kurosu, O. Miura, G. Oshikawa, 2015, Blood Cancer Journal.

Lymphoproliferative disorder risk after methotrexate treatment for rheumatoid arthritis

Keisuke Tanaka, C. Sakashita, Kouhei Yamamoto, 2023, Cancer science.

Molecular mechanisms for enhancement of stromal cell-derived factor 1–induced chemotaxis by platelet endothelial cell adhesion molecule 1 (PECAM-1)

T. Kurosu, O. Miura, G. Oshikawa, 2017, The Journal of Biological Chemistry.